• 1
    Ferlay J,Bray F,Pisani P,Parkin DM,GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. Lyon: IARC Press, 2004.
  • 2
    Yang BH,Bray FI,Parkin DM,Sellors JW,Zhang Z-F. Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer 2004; 109: 41824.
  • 3
    Parkin DM,Bray F,Ferlay J,Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74108.
  • 4
    Parkin DM,Bray F. The burden of HPV-related cancers. Vaccine 2006; 24 (Suppl 3, Chap 2): S11S25.
  • 5
    Sankaranarayanan R,Basu P,Wesley RS,Mahé C,Keita N,Mbalawa CCG,Sharma R,Dolo A,Shastri SS,Nacoulma M,Nayama M,Somanathan T, et al. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer 2004; 110: 90713.
  • 6
    Sankaranarayanan R,Wesley R,Thara S,Dhakad N,Chandralekha B,Sebastian P,Chithrathara K,Parkin DM,Nair MK. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer. 2003; 106: 4048.
  • 7
    Sankaranarayanan R,Shastri SS,Basu P,Mahe C,Mandal R,Amin G,Roy C,Muwonge R,Goswami S,Das P,Chinoy R,Frappart L, et al. The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia. Cancer Detect Prev 2004; 28: 34551.
  • 8
    Sankaranarayanan R,Thara S,Sharma A,Roy C,Shastri S,Mahe C,Muwonge R,Fontaniere B,The Multicentre Study Group On Cervical Cancer Early Detection In India. Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen 2004; 11: 7784.
  • 9
    Sankaranarayanan R,Chatterji R,Shastri SS,Basu P,Mahé C,Muwonge R,Seigneurin D,Somanathan T,Roy C,Kelkar R,Chinoy R,Dinshaw K, et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicentre study in India. Int J Cancer 2004; 112: 3417.
  • 10
    Arbyn M,Gaffikin L,Sankaranarayanan R,Muwonge R,Keita N,Wesley R,Tsu V. Assessment of Innovative Approaches to Cervical Cancer Screening, Follow-up and Treatment of Screen Detected Cervical Lesions in Developing Countries.A Pooled Analysis of ACCP Trial Results IPH/EPI-REPORTS 2005; 2: 1215. Seattle, Brussels: PATH & IPH, pp 1–215.
  • 11
    Sankaranarayanan R,Wesley RS. A practical manual on visual screening for cervical neoplasia. Lyon: IARC Press and World Health Organization Distribution and Sales, 2003: pp 149.
  • 12
    Lorincz AT. Methods of DNA hybridisation and their clinical applicability to human papillomavirus detection. In: FrancoEL,MonsonegoJ, eds. New developments in cervican cancer screening and prevention. Oxford: Blackwell Science, 1997: 32537.
  • 13
    Sharp S,Sterne J. Meta-analysis. Stata Tech Bull 1997: 914.
  • 14
    Sutton AJ,Abrams KR,Jones DR,Sheldon TA,Song F. Methods for meta-analysis in medical research. Chichester: Wiley, 2000: 317.
  • 15
    Chu H,Cole SR. Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol 2006; 59: 13312.
  • 16
    Rutter CM,Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 2002; 20: 286584.
  • 17
    Harbord RM,Deeks JJ,Egger M,Whiting P,Sterne JA. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics. 2007; 8: 23951.
  • 18
    Moses LE,Shapiro D,Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12: 1293316.
  • 19
    Elit L,Baigal G,Tan J,Munkhtaivan A. Assessment of 2 cervical screening methods in mongolia: cervical cytology and visual inspection with acetic Acid. J Low Genit Tract Dis 2006; 10: 838.
  • 20
    De Vuyst H,Claeys P,Njiru S,Muchiri L,Steyaert S,De Sutter P,van Marck E,Bwayo J,Temmerman M. Comparison of pap smear, visual inspection with acetic acid, human papillomavirus DNA-PCR testing and cervicography. Int J Gynecol Obstet 2005; 89: 1206.
  • 21
    Londhe M,George SS,Seshadri L. Detection of CIN by naked eye visualization after application of acetic acid. Indian J Cancer 1997; 34: 8891.
  • 22
    University of Zimbabwe/JHPIEGO, Anonymous. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. Lancet 1999; 353: 86973.
  • 23
    Cronje HS,Parham GP,Cooreman BF,de Beer A,Divall P,Bam RH. A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol 2003; 188: 395400.
  • 24
    Bhatla N,Mukhopadhyay A,Joshi S,Kumar A,Kriplani A,Pandey RM,Verma K. Visual inspection for cervical cancer screening: evaluation by doctors versus paramedical workers. Indian J Cancer 2004; 41: 326.
  • 25
    Denny L,Kuhn L,Pollack A,Wainwright H,Wright TC. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer. 2000; 89: 82633.
  • 26
    Cronje HS,Cooreman BF,Beyer E,Bam RH,Middlecote BD,Divall PD. Screening for cervical neoplasia in a developing country utilizing cytology, cervicographyand the acetic acid test. Int J Gynecol Obstet 2001; 72: 1517.
  • 27
    Sarian LO,Derchain SF,Naud P,Roteli-Martins C,Longatto-Filho A,Tatti S,Branca M,Erzen M,Serpa-Hammes L,Matos J,Gontijo RC,Braganca JF, et al. Evaluation of visual inspection with acetic acid (VIA). Lugol's iodine (VILI), cervical cytology and. HPV testing as cervical screening tools in Latin America. J Med Screen 2005; 12: 1429.
  • 28
    Sangwa-Lugoma G,Mahmud S,Nasr SH,Liaras J,Kayembe PK,Tozin RR,Drouin P,Lorincz A,Ferenczy A,Franco EL. Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. Int J Cancer 2006; 119: 138995.
  • 29
    Wright TC,Denny L,Kuhn L,Pollack A,Lorincz AT. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283: 816.
  • 30
    Womack SD,Chirenje ZM,Blumenthal PD,Gaffikin L,McGrath JA,Chipato T,Ngwalle E,Shah KV. Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe. BJOG 2000; 107: 338.
  • 31
    Belinson JL,Qiao YL,Pretorius R,Zhang WH,Elson P,Li L,Pan QJ,Fischer C,Lorincz AT,Zahniser D. Shanxi province cervical cancer screening study: a cross-sectional comparative trial multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001; 83: 43944.
  • 32
    Almonte M,Ferreccio C,Winkler JL,Cuzick J,Tsu V,Robles S,Takahashi R,Sasieni P. Cervical screening by visual inspection. HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer 2007; 121: 796802.
  • 33
    Franco EL. Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst Monogr 2003; 31: 8996.
  • 34
    Koliopoulos G,Arbyn M,Martin-Hirsch P,Kyrgiou M,Prendiville W,Paraskevaidis E. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non randomised studies. Gynecol Oncol 2007; 104: 23246.
  • 35
    Arbyn M,Sasieni P,Meijer CJ,Clavel C,Koliopoulos G,Dillner J. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006; 24( Suppl 3): 7889.
  • 36
    Cuzick J,Clavel C,Petry KU,Meijer CJ,Hoyer H,Ratnam S,Szarewski A,Birembaut P,Kulasingam S,Sasieni P,Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006; 119: 1095101.
  • 37
    Franceschi S,Rajkumar T,Vaccarella S,Gajalakshmi V,Sharmila A,Snijders PJ,Munoz N,Meijer CJ,Herrero R. Human papillomavirus and risk factors for cervical cancer in Chennai. India: a case-control study. Int. J Cancer. 2003; 107: 12733.
  • 38
    Franceschi S,Rajkumar R,Snijders PJ,Arslan A,Mahe C,Plummer M,Sankaranarayanan R,Cherian J,Meijer CJ,Weiderpass E. Papillomavirus infection in rural women in southern India. Br J Cancer 2005; 92: 6016.
  • 39
    Gage JC,Hanson VW,Abbey K,Dippery S,Gardner S,Kubota J,Schiffman M,Solomon D,Jeronimo J. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006; 108: 26472.
  • 40
    Jeronimo J,Schiffman M. Colposcopy at a crossroads. Am J Obstet Gynecol 2006; 195: 34953.
  • 41
    Pretorius RG,Zhang WH,Belinson JL,Huang MN,Wu LY,Zhang X,Qiao YL. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004; 191: 4304.
  • 42
    Pretorius RG,Kim RJ,Belinson JL,Elson P,Qiao YL. Inflation of sensitivity of cervical cancer screening tests secondary to correlated error in colposcopy. J Low Genit Tract Dis 2006; 10: 59.
  • 43
    Gaffikin L,McGrath JA,Arbyn M,Blumenthal PD. Accuracy of visual inspection with acetic acid as a cervical cancer test validated using Latent Class Analysis. BMC Med Res Methodol 2007; 7: 110.
  • 44
    Sankaranarayanan R,Esmy PO,Rajkumar R,Muwonge R,Swaminathan R,Shanthakumari S,Fayette JM,Cherian J. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu India: a cluster-randomised trial. Lancet 2007; 370: 398406.
  • 45
    Goldie S. CHAPTER 10 A public health approach to cervical cancer control: Considerations of screening and vaccination strategies. Int J Gynaecol Obstet 2006; 94( Suppl 1): S95S105.
  • 46
    Sherris J,Wright TC,Jr,Denny L,Sankaranarayanan R,Pollack AE,Sanghvi H,Sellors JW. Alliance for cervical cancer prevention: setting the record straight. Am J Public Health 2007; 97: 2001.